We are pleased to announce the addition of a new condition to our TreatGx medication decision support software. The Overactive Bladder treatment algorithm can now be accessed by all TreatGx users and includes pharmacotherapy options for adults with overactive bladder, including symptoms of urge urinary...
We are pleased to announce the addition of Atrial Fibrillation - Rhythm Control to our TreatGx medication decision support software. The Atrial Fibrillation - Rhythm Control algorithm can now be accessed by all TreatGx users. This algorithm provides long term medication treatment options for the maintenance of sinus rhythm in...
We are pleased to announce the addition of a new condition: Anxiety – Post-Traumatic Stress Disorder to our TreatGx medication decision support software. The PTSD treatment algorithm can be accessed by all TreatGx users. PTSD is a type of anxiety disorder which may develop after...
We are pleased to announce the addition of a new condition to our TreatGx website! Ulcerative colitis is now available for access to all TreatGx users. Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that can affect people of all ages. The disease can have a debilitating effect on quality...
We are pleased to announce the addition of two new conditions to our TreatGx medication decision support system. Alzheimer’s Disease and Insomnia can now be accessed by all TreatGx users. The Alzheimer’s algorithm provides treatment options for adults with mild, moderate, or severe Alzheimer’s disease, and includes guidance on medication titration and switching. Treatment options and dosing are based on the most up-to-date...
We are pleased to announce the addition of a new condition to our TreatGx website! Crohn’s disease is available for access to all TreatGx users. This algorithm provides medication treatment options for adults with mild, moderate and severe disease as well as for maintenance of...
